Cellular senescence in cancer: molecular mechanisms and therapeutic targets
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cellular senescence, a hallmark of aging and cancer, can both inhibit and promote tumor growth. Targeting senescent cells with senotherapeutics offers a promising cancer treatment strategy.
Area Of Science
- Gerontology and Oncology
- Cellular Biology and Cancer Research
Background
- Aging shares hallmarks with cancer, including cellular senescence, inflammation, and genomic instability.
- Cellular senescence plays a dual role in cancer, capable of both limiting tumor progression and promoting malignant phenotypes via the senescence-associated secretory phenotype.
- Targeting senescent cells presents a novel therapeutic avenue for cancer treatment.
Purpose Of The Study
- To describe cellular senescence, its characteristics, and its complex role in tumor biology.
- To introduce a novel "one-two-punch" therapeutic strategy involving senescence induction followed by senotherapeutic elimination.
- To review advances in senotherapeutics for cancer treatment, including drug categories and targeting strategies.
Main Methods
- Review of existing literature on cellular senescence and cancer biology.
- Description of the senescence-associated secretory phenotype and its role in tumor promotion.
- Outline of a "one-two-punch" therapeutic approach and current senotherapeutic applications.
Main Results
- Cellular senescence has a dual role in cancer, with established mechanisms for tumor suppression and emerging evidence for tumor promotion.
- The senescence-associated secretory phenotype is a key mediator of senescence's pro-tumorigenic effects.
- Senotherapeutics offer a promising strategy for cancer treatment by targeting senescent cells.
Conclusions
- Understanding the multifaceted role of cellular senescence in cancer is crucial for developing effective therapies.
- The "one-two-punch" strategy and senotherapeutics represent a promising frontier in cancer treatment.
- Further research into senotherapeutic screening, design, and targeting is warranted to optimize cancer therapy.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...